Marc Goldberg
SlowingNamed in filings at BioVentures InvestorsOn the current fund
- Board seats filed
- 8
Named in filings at BioVentures InvestorsOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Cerebral | Digital health | August 2025 | None on file |
| General Fluidics | Medical devices | July 2024 | None on file |
| BRAINBOX SOLUTIONS | Biotech & pharma | November 2020 | None on file |
| Oncoheroes Biosciences | Biotech & pharma | February 2018 | None on file |
| CohBar | Biotech & pharma | July 2017 | None on file |
| HYDROCISION | Medical devices | March 2017 | None on file |
| ENDOTRONIX | Digital health | July 2016 | SV Life Sciences |
| VERAX BIOMEDICAL | Medical devices | January 2015 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Marc Goldberg on the board, based on 8 filed seats with a verified or cited source.